Rebalix
Logo iSharesiShares · sheet of 10 September 2026
ETF sheet · official issuer and register data

iShares MSCI Europe Screened UCITS ETF

SAEU · IE00BFNM3D14 · EUR · domicile Ireland
Equity · Europe · Large & mid cap · Sustainable / ESGSFDR art. 8
Index tracked: MSCI EUROPE SCREENED NET Index
TER
0.12%+ trans. 0.02%
Fund size
4.8 bn EUR
Tracking difference
+0.31%3-year avg
🇮🇹 tax rate
26.00%white list 0.02%
Replication
Physical (optimised)
Income
Accumulating
Launch 19 Oct 2018 · costs from the KID as of 2 Sept 2026 · 365 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Funds’ assets, which reflects the return of the MSCI Europe Screened Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, that make up the Index. The Index measures the performance of a sub-set of equity securities which are part of the MSCI Europe Index (the “Parent…

Performance since series start (in euro) — base 100

19 Oct 201831 Aug 2026 · dividends reinvested where declared by the issuer
201920212023202522581223
High 225 (11 Aug 2026) · low 81 (18 Mar 2020) · last 223. Past performance is not indicative of future results.

Returns in euro

1 year+21.0%
3 years+53.8%
5 years+57.8%
10 yearsseries too young
Since series start+122.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.54%12.67%14.21%
Max drawdown−10.01%−16.61%−20.95%
Sharpe1.330.940.54
Sortino2.061.330.76
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · SAEU · IE00BFNM3D141
RebalixSAEU · IE00BFNM3D14 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+18.67%+18.33%+0.34%
2024+9.28%+9.00%+0.29%
2023+17.97%+17.67%+0.30%
2022−11.38%−11.60%+0.22%
2021+25.09%+24.77%+0.31%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 365 securities · top-10 weight = 23.1%
Top holdingsWeight
ASML HOLDING5.2%
HSBC HOLDINGS PLC2.8%
ROCHE PS PAR AG2.4%
NOVARTIS AG2.2%
ASTRAZENECA PLC2.0%
SIEMENS N AG1.9%
SAP1.8%
BANCO SANTANDER1.7%
ALLIANZ1.6%
SCHNEIDER ELECTRIC1.5%
Countries (% of fund)
United Kingdom20.0%France14.4%Germany13.7%Switzerland13.3%Netherlands10.1%
Sectors (% of fund)
Financials29.3%Industrials18.0%Health Care14.1%Information Technology10.3%Consumer Discretionary5.6%

Listing venues

ESMA register (FIRDS) and official exchange lists
SLMC · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/saeu-ishares-msci-e
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE00BFNM3D14
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · SAEU · IE00BFNM3D142